Drug Type Small molecule drug |
Synonyms TAK 960 |
Target |
Action inhibitors |
Mechanism PLK1 inhibitors(Polo like kinase 1 inhibitors) |
Therapeutic Areas |
Active Indication- |
Inactive Indication |
Originator Organization |
Active Organization- |
Inactive Organization |
Drug Highest PhaseDiscontinuedPhase 1 |
First Approval Date- |
Regulation- |
Molecular FormulaC27H34F3N7O3 |
InChIKeyGWRSATNRNFYMDI-UHFFFAOYSA-N |
CAS Registry1137868-52-0 |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
Advanced Malignant Solid Neoplasm | Phase 1 | United States | 01 Sep 2010 | |
Solid tumor | Phase 1 | United States | - | |
Acute Myeloid Leukemia | Preclinical | United States | - |
Phase 1 | 32 | qiznzfunig(wzcgcvitgu) = eugkasjizq qneedtypul (kiedlmlikn, daxmqdfeng - phmzbkyrqq) View more | - | 03 Mar 2014 |